Zhi Yang
Gründer bei Shanghai Bioveda Investment Management Consulting Co. Ltd.
Aktive Positionen von Zhi Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Gründer | 01.01.2005 | - |
Private Equity Investor | 01.01.2005 | - | |
Nexchem Pharmaceutical Co., Ltd.
Nexchem Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China. | Direktor/Vorstandsmitglied | 21.02.2011 | - |
BVCF Investment Consulting (Shanghai) Ltd.
BVCF Investment Consulting (Shanghai) Ltd. Investment ManagersFinance Part of Shanghai Bioveda Investment Management Consulting Co. Ltd., BVCF Investment Consulting (Shanghai) Ltd. is a healthcare investment company based in Shanghai, China. BVCF actively assists business owners and entrepreneurs to build their companies into world-class businesses. The Chinese company has raised five funds and invests in growth-stage healthcare companies from around the world, with a particular focus on innovative solutions that address unmet health needs. The company was founded by Zhi Yang and Ya Chao Zhao has been the CEO of the company since 2007. | Vorsitzender | 01.01.2005 | - |
Gründer | 01.01.2005 | - | |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Vorsitzender | 22.06.2018 | - |
Karriereverlauf von Zhi Yang
Ehemalige bekannte Positionen von Zhi Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.02.2014 | - |
Independent Dir/Board Member | 01.02.2014 | - | |
JAGUAR HEALTH, INC. | Direktor/Vorstandsmitglied | 01.02.2014 | - |
Independent Dir/Board Member | 01.02.2014 | - | |
NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Zhi Yang
Harvard University | Doctorate Degree |
Wuhan University | Undergraduate Degree |
Statistik
International
China | 5 |
Vereinigte Staaten | 5 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 4 |
Founder | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 6 |
Finance | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
JAGUAR HEALTH, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Shanghai Bioveda Investment Management Consulting Co. Ltd.
Shanghai Bioveda Investment Management Consulting Co. Ltd. Investment ManagersFinance Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets. | Finance |
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA. | Health Technology |
Nexchem Pharmaceutical Co., Ltd.
Nexchem Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China. | Health Technology |
BVCF Investment Consulting (Shanghai) Ltd.
BVCF Investment Consulting (Shanghai) Ltd. Investment ManagersFinance Part of Shanghai Bioveda Investment Management Consulting Co. Ltd., BVCF Investment Consulting (Shanghai) Ltd. is a healthcare investment company based in Shanghai, China. BVCF actively assists business owners and entrepreneurs to build their companies into world-class businesses. The Chinese company has raised five funds and invests in growth-stage healthcare companies from around the world, with a particular focus on innovative solutions that address unmet health needs. The company was founded by Zhi Yang and Ya Chao Zhao has been the CEO of the company since 2007. | Finance |